Novel Chemistry Development
At the core of our company's DEL services lies a dedication to pioneering new chemistry development and harnessing the potential of unique building block collections. Through continuous innovation, our company pushes the boundaries of compound synthesis, ensuring the creation of libraries rich in diversity and novelty. By leveraging cutting-edge synthetic methodologies and strategic partnerships, our company empowers clients with access to a vast array of compounds with unprecedented chemical space coverage.
Library Design
Our company's commitment to excellence extends to the design of bespoke DNA-encoded libraries, meticulously crafted to meet the specific requirements of each project. Drawing upon a wealth of expertise in synthetic and medicinal chemistry, our company collaborates closely with clients to conceptualize and design libraries optimized for target affinity and drug-like properties. This tailored approach not only enhances screening efficiency but also maximizes the likelihood of identifying lead compounds with desirable pharmacological profiles.
Library Production
Employing state-of-the-art synthesis technologies and rigorous quality control measures, our company delivers DELs characterized by exceptional reliability and reproducibility. By upholding uncompromising standards of quality, our company instills confidence in clients, enabling them to pursue drug discovery endeavors with assurance and precision.
DEL Screening
Our company's DEL screening capabilities epitomize efficiency and scalability, with billions of compounds screened against targets under diverse conditions. Leveraging advanced automation and informatics, our company accelerates the pace of discovery, facilitating the rapid identification of promising hits across a spectrum of target classes. Through data-driven analysis and selection, our company enables clients to navigate the vast landscape of chemical space with unparalleled precision, expediting the journey from hit identification to lead optimization.
Hit Analysis
Informatics lies at the heart of our company's hit analysis process, where data crunching and predictive modeling algorithms drive the identification of promising lead compounds. By mining vast datasets and analyzing structural-activity relationships, our company unveils hidden patterns and insights, guiding clients towards the most promising candidates for further optimization. Through the fusion of computational prowess and scientific expertise, our company empowers clients to make informed decisions and prioritize resources effectively, streamlining the drug discovery process.
Target Production & Assay Development
In addition to screening services, our company offers a suite of comprehensive solutions, including target production and assay development. By providing clients with access to high-quality protein targets and custom assay development services, our company streamlines the drug discovery workflow, enabling seamless integration of screening data into downstream processes. This holistic approach to drug discovery ensures that clients receive end-to-end support, from library design to hit identification, accelerating the translation of scientific insights into therapeutic breakthroughs.
